International Stem Cell Corp. (ISCO) Develops Breakthrough Technology to Treat Osteoarthritis
International Stem Cell Corp., a biotechnology company developing novel stem cell-based therapies, announced that its scientific team has developed a robust innovative technology to generate functional articular cartilage from the patient's own skin or adipose tissue to treat osteoarthritis. ISCO believes this technology may allow the company to provide relief to patients suffering from osteoarthritic knee joints, as well as to those with shoulder joints and intervertebral spinal disk osteoarthritis. Ruslan Semechkin, ISCO’s chief scientific officer, stated, "While we are working on obtaining regulatory approval for the Parkinson's disease treatment in Australia, as well as in the US, we are…